About myCORNER

myCORNER — from IN YOUR CORNER

When you register for myCORNER, you get access to an interactive Web site for women with early breast cancer and the people who care about them. You’ll get e-mails regularly about articles and tips on myCORNER that help keep you informed about breast cancer and healthy living. And you'll be able to connect with others when you build a profile and choose to make it searchable by other members.

and join myCORNER

Watch the video to learn more about all the things you can do at myCORNER.

Alternative content

To view the video, you need Adobe^® Acrobat^® Flash Player^® installed. If you do not have Adobe Acrobat Flash Player on your computer, you can download it from the Adobe Web site.

More to do at myCORNER

There's always lots to do at myCORNER, including

IN YOUR CORNER breast cancer support program.

and join myCORNER

Important Information About ARIMIDEX

ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.

ARIMIDEX is approved for the initial treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. Patients with hormone receptor-negative disease and patients who did not previously respond to tamoxifen therapy rarely responded to ARIMIDEX.

Important Safety Information About ARIMIDEX

Prescription ARIMIDEX is only for postmenopausal women. ARIMIDEX should not be taken if you are pregnant because it may harm your unborn child
Based on information from a study in patients with early breast cancer, women with a history of blockages in heart arteries (ischemic heart disease) who take ARIMIDEX may have a slight increase in this type of heart disease compared to similar patients who take tamoxifen
ARIMIDEX can cause bone softening/weakening (osteoporosis) increasing the chance of fractures. In a clinical study in early breast cancer, there were more fractures (including fractures of the spine, hip, and wrist) with ARIMIDEX (10%) than with tamoxifen (7%)
In a clinical study in early breast cancer, some patients taking ARIMIDEX had an increase in cholesterol. Skin reactions, allergic reactions, and changes in blood tests of liver function have also been reported
In the early breast cancer clinical trial, the most common side effects seen with ARIMIDEX include hot flashes, joint symptoms (including arthritis and arthralgia), weakness, mood changes, pain, back pain, sore throat, nausea and vomiting, rash, depression, high blood pressure, osteoporosis, fractures, swelling of arms/legs, insomnia, and headache
In advanced breast cancer trials, the most common side effects seen with ARIMIDEX versus tamoxifen include hot flashes, nausea, decreased energy and weakness, pain, back pain, headache, bone pain, increased cough, shortness of breath, sore throat, and swelling of arms and legs. Joint pain/stiffness has been reported in association with the use of ARIMIDEX
ARIMIDEX should not be taken with tamoxifen or estrogen-containing therapies

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

This site is intended for US consumers.

ARIMIDEX is a registered trademark and IN YOUR CORNER and myCORNER are trademarks of the AstraZeneca group of companies. All other registered trademarks are the property of their respective owners.